NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)

Podobne zapisy

• NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)
  od: Seed, M, i wsp.
  Wydane: (2009)
• Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
  od: Neil, A, i wsp.
  Wydane: (2003)
• Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
  od: Neil, H, i wsp.
  Wydane: (2003)
• Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.
  od: Neil, H, i wsp.
  Wydane: (2004)
• CURRENT STATIN TREATMENT OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH): RESULTS FROM THE ROYAL COLLEGE OF PHYSICIANS UK NATIONAL AUDIT
  od: Seed, M, i wsp.
  Wydane: (2011)